Nuveen Asset Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $431K | Buy |
201,535
+22,802
| +13% | +$48.8K | ﹤0.01% | 3031 |
|
|
2024
Q3 | $777K | Buy |
178,733
+56,730
| +46% | +$247K | ﹤0.01% | 2860 |
|
|
2024
Q2 | $569K | Buy |
+122,003
| New | +$569K | ﹤0.01% | 2943 |
|
|
2022
Q2 | – | Sell |
-86,043
| Closed | -$268K | – | 3246 |
|
|
2022
Q1 | $268K | Buy |
86,043
+1,996
| +2% | +$6.22K | ﹤0.01% | 3141 |
|
|
2021
Q4 | $419K | Sell |
84,047
-7,830
| -9% | -$39K | ﹤0.01% | 3114 |
|
|
2021
Q3 | $873K | Buy |
91,877
+1,230
| +1% | +$11.7K | ﹤0.01% | 3035 |
|
|
2021
Q2 | $1.11M | Buy |
90,647
+27,696
| +44% | +$338K | ﹤0.01% | 2972 |
|
|
2021
Q1 | $1.53M | Sell |
62,951
-441
| -0.7% | -$10.7K | ﹤0.01% | 2734 |
|
|
2020
Q4 | $2.03M | Sell |
63,392
-2,145
| -3% | -$68.8K | ﹤0.01% | 2502 |
|
|
2020
Q3 | $1.98M | Buy |
65,537
+16,426
| +33% | +$497K | ﹤0.01% | 2394 |
|
|
2020
Q2 | $2.07M | Buy |
49,111
+13,047
| +36% | +$550K | ﹤0.01% | 2326 |
|
|
2020
Q1 | $900K | Buy |
+36,064
| New | +$900K | ﹤0.01% | 2556 |
|